Target intelligence / Profile preview

Cancer Cell (Direct Lysis)

Molecular classification
Cellular Process
01

Overview

The term "Cancer cell (direct lysis)" refers to the process by which immune effector cells—primarily cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells—directly induce the death of cancer cells through lytic mechanisms. This involves granule-mediated cytotoxicity (perforin/granzyme) and death receptor-mediated cytotoxicity (FasL/FasR, TRAIL/TRAIL-R). It is a fundamental aspect of immune surveillance and immunotherapy, where the goal is to eliminate malignant cells via direct cytotoxicity.

Other names
Tumor Cell LysisDirect Cytotoxicity of Cancer CellsCancer Cell Killing
02

Mechanism of action

Direct lysis of cancer cells through granule-mediated cytotoxicity (perforin/granzyme) and death receptor-mediated cytotoxicity (FasL/FasR, TRAIL/TRAIL-R).

03

Biological functions

Cell DeathImmune ResponseTumor Suppression
04

Disease associations

Cancer
05

Safety considerations

Cytokine Release Syndrome (CRS)On-target, off-tumor toxicityImmune-related adverse events (irAEs)Tumor lysis syndrome
06

Interacting drugs

Monoclonal Antibodies (e.g., Rituximab, Trastuzumab)

3 more in the full profile.

07

Biomarkers

PD-L1 expressionTumor Mutational Burden (TMB)Microsatellite Instability (MSI)Expression of target antigens (e.g., HER2, CD20)Immune cell infiltration

Beyond the preview

Go deeper on Cancer Cell (Direct Lysis).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cancer Cell (Direct Lysis).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call